DE69832053D1 - Humane Polypeptide und Poylnucleotide mit einer Homologie zum Testis-spezifischen Angiotensin konvertierenden Enzyms - Google Patents

Humane Polypeptide und Poylnucleotide mit einer Homologie zum Testis-spezifischen Angiotensin konvertierenden Enzyms

Info

Publication number
DE69832053D1
DE69832053D1 DE69832053T DE69832053T DE69832053D1 DE 69832053 D1 DE69832053 D1 DE 69832053D1 DE 69832053 T DE69832053 T DE 69832053T DE 69832053 T DE69832053 T DE 69832053T DE 69832053 D1 DE69832053 D1 DE 69832053D1
Authority
DE
Germany
Prior art keywords
testis
polynucleotides
homology
converting enzyme
angiotensin converting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69832053T
Other languages
English (en)
Other versions
DE69832053T2 (de
Inventor
Christopher D Southan
Nicola Burgess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810373.2A external-priority patent/GB9810373D0/en
Priority claimed from GBGB9818009.4A external-priority patent/GB9818009D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69832053D1 publication Critical patent/DE69832053D1/de
Publication of DE69832053T2 publication Critical patent/DE69832053T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69832053T 1998-05-13 1998-10-27 Humane Polypeptide und Poylnucleotide mit einer Homologie zum Testis-spezifischen Angiotensin konvertierenden Enzyms Expired - Fee Related DE69832053T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9810373 1998-05-13
GBGB9810373.2A GB9810373D0 (en) 1998-05-13 1998-05-13 Novel compounds
GB9818009 1998-08-18
GBGB9818009.4A GB9818009D0 (en) 1998-08-18 1998-08-18 Novel compounds

Publications (2)

Publication Number Publication Date
DE69832053D1 true DE69832053D1 (de) 2005-12-01
DE69832053T2 DE69832053T2 (de) 2006-07-20

Family

ID=26313679

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832053T Expired - Fee Related DE69832053T2 (de) 1998-05-13 1998-10-27 Humane Polypeptide und Poylnucleotide mit einer Homologie zum Testis-spezifischen Angiotensin konvertierenden Enzyms

Country Status (4)

Country Link
EP (1) EP0974664B1 (de)
JP (1) JPH11318472A (de)
CA (1) CA2248987A1 (de)
DE (1) DE69832053T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989363B1 (en) 1997-12-11 2006-01-24 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
US6610497B1 (en) 1997-12-11 2003-08-26 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor
AU4691900A (en) * 1999-05-13 2000-12-05 Zymogenetics Inc. Zace2: a human metalloenzyme
EP1276764A4 (de) * 2000-04-03 2004-09-08 Human Genome Sciences Inc Menschliche polynukleotide, polypeptide und antikörper
AU2001284794A1 (en) * 2000-08-09 2002-02-18 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and uses therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807703A (en) * 1996-06-17 1998-09-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US6989363B1 (en) * 1997-12-11 2006-01-24 Millennium Pharmaceuticals, Inc. Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor

Also Published As

Publication number Publication date
EP0974664A3 (de) 2003-02-26
JPH11318472A (ja) 1999-11-24
DE69832053T2 (de) 2006-07-20
EP0974664B1 (de) 2005-10-26
EP0974664A2 (de) 2000-01-26
CA2248987A1 (en) 1999-11-13

Similar Documents

Publication Publication Date Title
ATE342915T1 (de) Chimäres lösliches interleukin-6 rezeptor/ligand protein, analoge und verwendungen
PT1151008E (pt) Peptidos artificiais com actividade de superficie e sua utilizacao na preparacao de tensioactivos artificiais
DE69821218D1 (de) Modifizierte ionomere mit verbesserten eigenschaften und verarbeitbarkeit
HUP0102535A3 (en) Cd19xcd3 specific polypeptides and uses thereof
DE69940431D1 (de) Brennstoffzellensystem und zellensteuerungsverfahren
DE69712003D1 (de) Modifikation von xylanase zur Verbesserung von Thermophilicität, alkophilicität und thermostabilität
DE69807926T2 (de) Hautpflegemittel mit verbesserter hauthydratisierung
DE69817302D1 (de) Verbesserungen an/und im Zusammenhang mit Ventilen
DE69832053D1 (de) Humane Polypeptide und Poylnucleotide mit einer Homologie zum Testis-spezifischen Angiotensin konvertierenden Enzyms
DE69810762T2 (de) Algizides und fungizides konservierungsmittel mit alternaria-aktivität
GB2341578B (en) Improvements in or relating to roofing and roofing materials
IL146527A0 (en) Polynucleotides and polypeptides encoded thereby distantly homolgous to heparanse
AU5586500A (en) Human sel-10 polypeptides and polynucleotides that encode them
FR2761363B1 (fr) Polypeptide purifie de l'epiderme et son utilisation
DE69735694D1 (de) Polypeptide mit L-Asparaginase Aktivität
DE69801651T2 (de) Überwachung und steuerung von kanälen zur verbesserung von anrufschnittstellen
EP1131350A4 (de) Egf-ähnliche nukleinsäuren und polypeptide und deren anwendungen
IT1310165B1 (it) Dispositivo e procedimento per controllare uno scaldacqua.
DE69840550D1 (de) Polypeptide und polynukleotide und deren verwendungen
DE69835939D1 (de) Drehkontrollvorrichtung und drehkontrollverfahren
NO20023015L (no) Humant heparanasebeslektet polypeptid og nukleinsyre
GB2348445B (en) Improvements in and relating to roofing structures,particularly obstructions on roofs
NO20006091D0 (no) Humant protein C-polypeptid
ES2020161A4 (es) Material de estanqueidad acrilico prefabricado y su aplicacion en la estanqueidad de cubiertas y de sub-cubiertas.
EP1242580A4 (de) Verfahren und materialien im zusammenhang mit semaphorin-artigen polypeptiden und polynukleotiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee